La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Dopamine Agents »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine < Dopamine Agents < Dopamine Agonists  Facettes :

List of bibliographic references indexed by Dopamine Agents

Number of relevant bibliographic references: 97.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000222 (2016) Mauro Pettorruso [Italie] ; Alfonso Fasano [Canada] ; Luisa De Risio [Italie] ; Lucia Ricciardi [Royaume-Uni] ; Marco Di Nicola [Italie] ; Giovanni Martinotti [Italie] ; Luigi Janiri [Italie] ; Anna Rita Bentivoglio [Italie]Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity.
000302 (2016) Connie Marras [Canada] ; Nathan Herrmann [Canada] ; Hadas D. Fischer [Canada] ; Kinwah Fung [Canada] ; Andrea Gruneir [Canada] ; Paula A. Rochon [Canada] ; Soham Rej [Canada] ; Simone Vigod [Canada] ; Dallas Seitz [Canada] ; Kenneth I. Shulman [Canada]Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications.
000314 (2016) F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada]Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
000398 (2016) Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle BoileauD3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000407 (2016) A Jon Stoessl [Canada]Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
000413 (2016) John L. Goudreau [États-Unis] ; Adriana Pérez [États-Unis] ; Michael J. Aminoff [États-Unis] ; James T. Boyd [États-Unis] ; Keith D. Burau [États-Unis] ; Chadwick W. Christine [États-Unis] ; Maureen Leehey [États-Unis] ; John C. Morgan [États-Unis]Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America.
000470 (2015) Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000474 (2015) Tiago A. Mestre [Canada] ; Isabelle Beaulieu-Boire [Canada] ; Camila C. Aquino [Canada] ; Nicolas Phielipp [États-Unis] ; Yu Yan Poon [Canada] ; Jane P. Lui [Canada] ; Julie So [Canada] ; Susan H. Fox [Canada]What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?
000476 (2015) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Virtually-induced threat in Parkinson's: Dopaminergic interactions between anxiety and sensory-perceptual processing while walking.
000505 (2015) Matt J N. Brown [Canada] ; Quincy J. Almeida ; Fariborz RahimiThe dopaminergic system in upper limb motor blocks (ULMB) investigated during bimanual coordination in Parkinson's disease (PD).
000522 (2015) Tom M. Johnston [Canada] ; Susan H. FoxSymptomatic Models of Parkinson's Disease and L-DOPA-Induced Dyskinesia in Non-human Primates.
000527 (2015) Fariborz Rahimi [Canada] ; Carina Bee [Irlande (pays)] ; David Wang [Canada] ; Farrokh Janabi-Sharifi [Canada] ; Quincy J. Almeida [Canada]Subgroup analysis of PD tremor with loading: action tremor as a combination of classical rest and physiological tremor.
000599 (2015) Lorraine V. Kalia [Canada] ; Anthony E. Lang [Canada]Parkinson's disease.
000619 (2015) Hooman Ganjavi [Canada] ; Penny A. MacdonaldON-OFF Effects of Dopaminergic Therapy on Psychiatric Symptoms in Parkinson's Disease.
000630 (2015) Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex RajputNeuroleptic‐induced Parkinsonism: Clinicopathological study
000687 (2015) David Mongeon [Canada] ; Pierre Blanchet ; Stéphanie Bergeron ; Julie MessierImpact of Parkinson's disease on proprioceptively based on-line movement control.
000828 (2015) Kaylena A. Ehgoetz Martens [Canada] ; Colin G. Ellard [Canada] ; Quincy J. Almeida [Canada]Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson's disease.
000904 (2014) Magda Osman [Royaume-Uni] ; Agata Ryterska [Royaume-Uni] ; Kash Karimi [Royaume-Uni] ; Lingling Tu [République populaire de Chine] ; Ignacio Obeso [Canada] ; Maarten Speekenbrink [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni]The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
000933 (2014) Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
000991 (2014) Chizoba C. Umeh [États-Unis] ; Adriana Pérez [États-Unis] ; Erika F. Augustine [États-Unis] ; Rohit Dhall [États-Unis] ; Richard B. Dewey [États-Unis] ; Zoltan Mari [États-Unis] ; David K. Simon [États-Unis] ; Anne-Marie A. Wills [États-Unis] ; Chadwick W. Christine [États-Unis] ; Jay S. Schneider [États-Unis] ; Oksana Suchowersky [Canada]No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial
000B26 (2014) Silke Appel-Cresswell [Canada] ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex RajputClinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Dopamine Agents" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Dopamine Agents" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Dopamine Agents
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022